Principal Investigator
Jonathan Trent
Enrollment Status
Closed
Clinical Trial ID
Institutional Protocol #
20211168
Clinical Trial Summary
A Phase 1/2 Study of the Safety, Pharmacokinetics and Anti-
Tumor Activity of the Oral KIT Inhibitor THE-630 in Patients
with Advanced Gastrointestinal Stromal Tumors (GIST)
Phase
Phase I/II
Funding Agency/Sponsor
Industrial
Disease
Bone and Soft Tissue Cancers
Contact Information
Phone Number
+1 (407) 7659589